$SBRA
Sabra Health Care REIT, Inc.

2012 Q2 Form 10-Q Financial Statement

#000149229812000041 Filed on August 02, 2012

View on sec.gov

Income Statement

Concept 2012 Q2 2011 Q2
Revenue $25.12M $18.81M
YoY Change 33.57%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.500M $2.900M
YoY Change 20.69%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.557M $6.290M
YoY Change 20.14%
% of Gross Profit
Operating Expenses $11.00M $9.200M
YoY Change 19.57%
Operating Profit
YoY Change
Interest Expense -$7.900M -$7.500M
YoY Change 5.33%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $5.900M $2.100M
YoY Change 180.95%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings $5.923M $2.087M
YoY Change 183.8%
Net Earnings / Revenue 23.58% 11.1%
Basic Earnings Per Share $0.16 $0.08
Diluted Earnings Per Share $0.16 $0.08
COMMON SHARES
Basic Shares Outstanding 37.15M shares 25.15M shares
Diluted Shares Outstanding 37.19M shares 25.23M shares

Balance Sheet

Concept 2012 Q2 2011 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.100M $3.500M
YoY Change -11.43%
Cash & Equivalents $3.110M $3.454M
Short-Term Investments
Other Short-Term Assets $23.00M $17.90M
YoY Change 28.49%
Inventory $542.6M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $26.10M $564.0M
YoY Change -95.37%
LONG-TERM ASSETS
Property, Plant & Equipment $698.6M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $32.60M $31.80M
YoY Change 2.52%
Total Long-Term Assets $752.4M $31.80M
YoY Change 2265.95%
TOTAL ASSETS
Total Short-Term Assets $26.10M $564.0M
Total Long-Term Assets $752.4M $31.80M
Total Assets $778.5M $595.8M
YoY Change 30.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.20M $8.700M
YoY Change 28.74%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $36.70M $35.00M
YoY Change 4.86%
LONG-TERM LIABILITIES
Long-Term Debt $425.4M $384.9M
YoY Change 10.52%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $425.4M $384.9M
YoY Change 10.52%
TOTAL LIABILITIES
Total Short-Term Liabilities $36.70M $35.00M
Total Long-Term Liabilities $425.4M $384.9M
Total Liabilities $462.1M $420.0M
YoY Change 10.03%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $371.0K $251.0K
YoY Change 47.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $316.4M $175.8M
YoY Change
Total Liabilities & Shareholders Equity $778.5M $595.8M
YoY Change 30.67%

Cashflow Statement

Concept 2012 Q2 2011 Q2
OPERATING ACTIVITIES
Net Income $5.923M $2.087M
YoY Change 183.8%
Depreciation, Depletion And Amortization $7.557M $6.290M
YoY Change 20.14%
Cash From Operating Activities $7.600M $5.400M
YoY Change 40.74%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$37.30M -$74.00M
YoY Change -49.59%
Cash From Investing Activities -$37.30M -$74.00M
YoY Change -49.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 30.00M -8.200M
YoY Change -465.85%
NET CHANGE
Cash From Operating Activities 7.600M 5.400M
Cash From Investing Activities -37.30M -74.00M
Cash From Financing Activities 30.00M -8.200M
Net Change In Cash 300.0K -76.80M
YoY Change -100.39%
FREE CASH FLOW
Cash From Operating Activities $7.600M $5.400M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q2 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
11181000 USD
CY2011Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
14139000 USD
CY2011Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
18791000 USD
CY2012Q2 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
33218000 USD
CY2011Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
344995000 USD
CY2012Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
349272000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2478000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4135000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-8000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-8000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
995000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1447000 USD
CY2011Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
500000 USD
CY2012Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
900000 USD
CY2012Q2 us-gaap Assets
Assets
778518000 USD
CY2011Q4 us-gaap Assets
Assets
749650000 USD
CY2012Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
670605000 USD
CY2011Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
626877000 USD
CY2012Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
400000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
900000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42250000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3110000 USD
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3454000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
74233000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-70779000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-39140000 USD
CY2012Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.32
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.66
CY2012Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.33
CY2012Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.33
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
369000 USD
CY2012Q2 us-gaap Common Stock Value
CommonStockValue
371000 USD
CY2012Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
25540000 USD
CY2011Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
25540000 USD
CY2012Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36891712 shares
CY2012Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37051242 shares
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36891712 shares
CY2012Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37051242 shares
CY2012Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7557000 USD
CY2011Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6290000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14860000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12377000 USD
us-gaap Dividends Common Stock
DividendsCommonStock
-8051000 USD
us-gaap Dividends Common Stock
DividendsCommonStock
-24755000 USD
CY2012Q2 us-gaap Due From Affiliates
DueFromAffiliates
0 USD
CY2011Q4 us-gaap Due From Affiliates
DueFromAffiliates
0 USD
CY2012Q2 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
0 USD
CY2011Q4 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
0 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2011Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2011Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2011Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
44045000 USD
CY2012Q2 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
46043000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7810000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5592000 USD
CY2012Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3489000 USD
CY2011Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2923000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
485000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1914000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
779000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-219000 USD
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
2008000 USD
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
1825000 USD
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
26322 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
69794 shares
CY2012Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
43745 shares
CY2011Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
71895 shares
us-gaap Interest Expense Debt
InterestExpenseDebt
15846000 USD
CY2012Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
8148000 USD
CY2011Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
7505000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
15103000 USD
us-gaap Interest Paid
InterestPaid
14677000 USD
us-gaap Interest Paid
InterestPaid
14476000 USD
CY2011Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
4000000 USD
CY2012Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
3700000 USD
CY2012Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
0 USD
CY2011Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
0 USD
CY2011Q4 us-gaap Land
Land
91731000 USD
CY2012Q2 us-gaap Land
Land
100941000 USD
CY2012Q2 us-gaap Land Improvements
LandImprovements
4640000 USD
CY2011Q4 us-gaap Land Improvements
LandImprovements
4640000 USD
CY2011Q4 us-gaap Liabilities
Liabilities
423077000 USD
CY2012Q2 us-gaap Liabilities
Liabilities
462093000 USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
749650000 USD
CY2012Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
778518000 USD
CY2012Q2 us-gaap Line Of Credit
LineOfCredit
42500000 USD
CY2011Q4 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2011Q4 us-gaap Loans Receivable Net
LoansReceivableNet
0 USD
CY2012Q2 us-gaap Loans Receivable Net
LoansReceivableNet
21193000 USD
CY2012Q2 us-gaap Long Term Debt
LongTermDebt
424880000 USD
CY2012Q2 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
284876000 USD
CY2012Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
1920000 USD
CY2012Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
128791000 USD
CY2012Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
3902000 USD
CY2012Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3690000 USD
CY2012Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
1701000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9273000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14229000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-77456000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-79434000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17928000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
24087000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
5923000 USD
CY2011Q2 us-gaap Net Income Loss
NetIncomeLoss
2087000 USD
us-gaap Net Income Loss
NetIncomeLoss
10328000 USD
us-gaap Net Income Loss
NetIncomeLoss
3335000 USD
CY2012Q2 us-gaap Operating Leases Future Minimum Payments Receivable
OperatingLeasesFutureMinimumPaymentsReceivable
1167026000 USD
CY2012Q2 us-gaap Operating Leases Future Minimum Payments Receivable Current
OperatingLeasesFutureMinimumPaymentsReceivableCurrent
50633000 USD
CY2012Q2 us-gaap Operating Leases Future Minimum Payments Receivable Thereafter
OperatingLeasesFutureMinimumPaymentsReceivableThereafter
711325000 USD
CY2012Q2 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
24820000 USD
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
36190000 USD
CY2011Q2 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
18628000 USD
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
48483000 USD
us-gaap Proceeds From Loan Originations1
ProceedsFromLoanOriginations1
-21176000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
21947000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
CY2012Q2 us-gaap Operating Leases Future Minimum Payments Receivable In Five Years
OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears
101267000 USD
CY2012Q2 us-gaap Operating Leases Future Minimum Payments Receivable In Four Years
OperatingLeasesFutureMinimumPaymentsReceivableInFourYears
101267000 USD
CY2012Q2 us-gaap Operating Leases Future Minimum Payments Receivable In Three Years
OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears
101267000 USD
CY2012Q2 us-gaap Operating Leases Future Minimum Payments Receivable In Two Years
OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears
101267000 USD
us-gaap Other Noncash Income
OtherNoncashIncome
-9000 USD
us-gaap Other Noncash Income
OtherNoncashIncome
0 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
8051000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
24463000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
270000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
3435000 USD
us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
730000 USD
us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
86000 USD
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
5348000 USD
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
0 USD
us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
74000000 USD
us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
55550000 USD
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
547000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
144000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
42500000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
us-gaap Proceeds From Loan Originations1
ProceedsFromLoanOriginations1
0 USD
CY2011Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
108916000 USD
CY2012Q2 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
123651000 USD
CY2011Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
767293000 USD
CY2012Q2 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
822229000 USD
CY2011Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
658377000 USD
CY2012Q2 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
698578000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
1499000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
22464000 USD
CY2012Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
7076000 USD
CY2011Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
6093000 USD
us-gaap Revenue Recognition Interest
RevenueRecognitionInterest
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Interest Income</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest income on the Company&#8217;s loans receivable is recognized on an accrual basis over the life of the investment using the interest method. Direct loan origination costs are amortized over the term of the loan as an adjustment to interest income. When concerns exist as to the ultimate collection of principal or interest due under a loan, the loan is placed on nonaccrual status and the Company will not recognize interest income until the cash is received, or the loan returns to accrual status. If the Company determines the collection of interest according to the contractual terms of the loan is probable, the Company will resume the accrual of interest.</font></div></div>
CY2012Q2 us-gaap Revenues
Revenues
25117000 USD
us-gaap Revenues
Revenues
48844000 USD
CY2011Q2 us-gaap Revenues
Revenues
18805000 USD
us-gaap Revenues
Revenues
36407000 USD
CY2011Q4 us-gaap Secured Debt
SecuredDebt
158398000 USD
CY2012Q2 us-gaap Secured Debt
SecuredDebt
157872000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2478000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3842000 USD
CY2011Q3 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1500000 shares
CY2011Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
11700000 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
547000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
144000 USD
CY2011Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
163900000 USD
CY2012Q2 us-gaap Stockholders Equity
StockholdersEquity
316425000 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
326573000 USD
CY2011Q2 us-gaap Stockholders Equity
StockholdersEquity
175842000 USD
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
177533000 USD
us-gaap Straight Line Rent
StraightLineRent
128000 USD
us-gaap Straight Line Rent
StraightLineRent
1690000 USD
CY2012Q2 us-gaap Unsecured Debt
UnsecuredDebt
225000000 USD
CY2011Q4 us-gaap Unsecured Debt
UnsecuredDebt
225000000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>
CY2011Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25226179 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37119005 shares
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37191687 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25210575 shares
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37147942 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37092683 shares
CY2011Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25154284 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25140781 shares
sbra Income Loss From Subsidiaries
IncomeLossFromSubsidiaries
0 USD
CY2011Q2 sbra Income Loss From Subsidiaries
IncomeLossFromSubsidiaries
0 USD
CY2012Q2 sbra Income Loss From Subsidiaries
IncomeLossFromSubsidiaries
0 USD
sbra Income Loss From Subsidiaries
IncomeLossFromSubsidiaries
0 USD
CY2011Q2 sbra Interest Income
InterestIncome
177000 USD
CY2012Q2 sbra Interest Income
InterestIncome
297000 USD
sbra Interest Income
InterestIncome
361000 USD
sbra Interest Income
InterestIncome
217000 USD
CY2012Q2 sbra Liability For Uncertain Tax Positions
LiabilityForUncertainTaxPositions
25540000 USD
CY2011Q4 sbra Liability For Uncertain Tax Positions
LiabilityForUncertainTaxPositions
25540000 USD
CY2011Q4 sbra Loan Receivable Face Value
LoanReceivableFaceValue
0 USD
CY2012Q2 sbra Loan Receivable Face Value
LoanReceivableFaceValue
21000000 USD
CY2012Q2 sbra Operating Leases Weighted Average Lease Expiration Period
OperatingLeasesWeightedAverageLeaseExpirationPeriod
P12Y
sbra Payments For Proceeds From Intercompany Financing Investing Activities
PaymentsForProceedsFromIntercompanyFinancingInvestingActivities
0 USD
sbra Payments For Proceeds From Intercompany Financing Investing Activities
PaymentsForProceedsFromIntercompanyFinancingInvestingActivities
0 USD
sbra Payments Of Distributions To Parent
PaymentsOfDistributionsToParent
0 USD
sbra Payments Of Distributions To Parent
PaymentsOfDistributionsToParent
0 USD
CY2011Q4 sbra Prepaid Expenses Deferred Financing Costs And Other Assets
PrepaidExpensesDeferredFinancingCostsAndOtherAssets
17390000 USD
CY2012Q2 sbra Prepaid Expenses Deferred Financing Costs And Other Assets
PrepaidExpensesDeferredFinancingCostsAndOtherAssets
23021000 USD
sbra Proceeds From Distributions To Parent Investing Activities
ProceedsFromDistributionsToParentInvestingActivities
0 USD
sbra Proceeds From Distributions To Parent Investing Activities
ProceedsFromDistributionsToParentInvestingActivities
0 USD
CY2011Q3 sbra Stock Issued During Period Price Per Share
StockIssuedDuringPeriodPricePerShare
14.75
CY2011Q2 sbra Total Expenses
TotalExpenses
16718000 USD
sbra Total Expenses
TotalExpenses
38516000 USD
sbra Total Expenses
TotalExpenses
33072000 USD
CY2012Q2 sbra Total Expenses
TotalExpenses
19194000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Period End Date
DocumentPeriodEndDate
2012-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001492298
CY2012Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
37051242 shares
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Sabra Health Care REIT, Inc.

Files In Submission

Name View Source Status
0001492298-12-000041-index-headers.html Edgar Link pending
0001492298-12-000041-index.html Edgar Link pending
0001492298-12-000041.txt Edgar Link pending
0001492298-12-000041-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sbra-20120630.xml Edgar Link completed
sbra-20120630.xsd Edgar Link pending
sbra-20120630_cal.xml Edgar Link unprocessable
sbra-20120630_def.xml Edgar Link unprocessable
sbra-20120630_lab.xml Edgar Link unprocessable
sbra-20120630_pre.xml Edgar Link unprocessable
sbra10q2012q2.htm Edgar Link pending
sbraex1212012q2.htm Edgar Link pending
sbraex3112012q2.htm Edgar Link pending
sbraex3122012q2.htm Edgar Link pending
sbraex3212012q2.htm Edgar Link pending
sbraex3222012q2.htm Edgar Link pending
Show.js Edgar Link pending